Forrest Xu

Head of medical department, Greater China/Senior director

About

1.More than 20 years’ experience in medical role for investigational new drugs, new launch products and matured products, including medical affairs, clinical research, medical information, PV, real world data/big data analysis, Artificial Intelligence(AI) research area and demonstrated outstanding performance in these roles. In-depth understanding of the whole process of drug R&D and Commercialization and related laws and regulations 2.More than 10 years team management experience and demonstrated cross functional leadership skills, team management and people development skills through innovative OKR (Objective Key Results) and Kaizen management model. 3.Robust international outlook and cross-therapeutic area expertise, demonstrating significant contributions with focused, sharp business acumen and strong innovation under compliance.

Country

China

City

Beijing

Industry

Pharmaceuticals

Skill

Statistics, Medical Marketing, medical information, Real World Evidence (RWE), KOL Management, evidence generation, People Management, Artificial Intelligence (AI), New product launch, Medical Affairs, Market access( reimbursement), Strategy, Pharmacovigilance, Team Leadership, Project Management, Team Management, Good Clinical Practice (GCP), Cross-functional Team Leadership, Clinical Research, Product Lifecycle Management

Experience

Head of medical department, Greater China/Senior director

GE Healthcare（China）Co.，Ltd

2018-9 - Present · 8 yrs 1 mo

  Report directly to Chief Medical Officer.  Lead sized team including MA, MSL, MI, PV, AI research role to manage all lifecycle of inline and pipeline drugs for China Mainland, Taiwan, Hongkong and Macao.  Focus on the oncology, neurology, cardiology and molecular imaging area etc.

Medical director /MSL team lead /MA TA Manager/ Medical advisor

Pfizer

2010-11 - 2018-9 · 7 yrs 11 mos

 Lead team to create innovative medical model including real word study, clinical decision support system (CDSS) etc. to support medical value expansion.  Lead CVM&CNS MSL team to deliver on the field Medical Plan for CVM&CNS marketed products (Lipitor, Zoloft etc.)  Lead team to develop China new product life-cycle management strategy in anticoagulants area (Eliquis etc.) and provide medical evaluation for license in products

Medical Science Liaison

GSK

2009-8 - 2010-11 · 1 yr 4 mos

Field medical support in CVM&CNS area: KOL engagement, Academic meeting support etc.

Medical Affairs Specialist

Eisai China Holdings Ltd.

2008-1 - 2009-8 · 1 yr 8 mos

 In charge of MA, MI, PV role to support on lead products, which focus on neurology, endocrinology, Orthopedics, digestion area.

Clinical research associate/ supervisor

WeiXin Bio. Tech. Ltd. company of Peking university

2004-8 - 2008-1 · 3 yrs 6 mos

 Phase I-III clinical trials monitoring，in-depth understanding of clinical statistics and clinical trial related regulations.  Assist in writing the files of clinical section of SFDA new drug application.  Phase IV study or post marketing study idea development and management.  Assist in the US-FDA investigational new drug application and phase I study.  New license in product medical evaluation.